FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2163136018> ?p ?o ?g. }

• W2163136018 endingPage "51" @default.
• W2163136018 startingPage "46" @default.
• W2163136018 abstract "Clopidogrel is a prodrug that has to be converted to an active metabolite by hepatic cytochrome P450 (CYP) isoenzymes to inhibit platelet aggregation. Individual variability of platelet inhibition by clopidogrel suggests a possibility for genetic factors having a significant influence on clopidogrel responsiveness. In this study, we sought to determine the relation of genetic polymorphisms of CYP genes to clopidogrel resistance in Koreans. Four hundred fifty patients who underwent successful percutaneous coronary intervention with drug-eluting stents were randomly assigned to treatment with dual antiplatelet regimen (aspirin plus clopidogrel) or triple antiplatelet regimen (aspirin plus clopidogrel plus cilostazol). Clopidogrel resistance using VerifyNow P2Y12 assay and genetic analysis were performed in 387 patients. Clopidogrel resistance was found in 112 patients (28.9%). In the clopidogrel-responsive group, there was a significantly higher proportion of cilostazol use. Because cilostazol showed a significant influence on clopidogrel resistance, we examined the association of single-nucleotide polymorphisms and clopidogrel resistance in the dual and triple antiplatelet therapy groups, respectively. In all subjects, the CYP2C19*3A allele was significantly more prevalent in the clopidogrel-resistant group compared with the clopidogrel-responsive group. Multiple logistic regression analysis demonstrated that CYP2C19*3 is an independent predictor of clopidogrel resistance. In conclusion, CYP2C19*3 single-nucleotide polymorphisms is an independent risk factor of clopidogrel resistance in Korean subjects with coronary artery disease. Clopidogrel is a prodrug that has to be converted to an active metabolite by hepatic cytochrome P450 (CYP) isoenzymes to inhibit platelet aggregation. Individual variability of platelet inhibition by clopidogrel suggests a possibility for genetic factors having a significant influence on clopidogrel responsiveness. In this study, we sought to determine the relation of genetic polymorphisms of CYP genes to clopidogrel resistance in Koreans. Four hundred fifty patients who underwent successful percutaneous coronary intervention with drug-eluting stents were randomly assigned to treatment with dual antiplatelet regimen (aspirin plus clopidogrel) or triple antiplatelet regimen (aspirin plus clopidogrel plus cilostazol). Clopidogrel resistance using VerifyNow P2Y12 assay and genetic analysis were performed in 387 patients. Clopidogrel resistance was found in 112 patients (28.9%). In the clopidogrel-responsive group, there was a significantly higher proportion of cilostazol use. Because cilostazol showed a significant influence on clopidogrel resistance, we examined the association of single-nucleotide polymorphisms and clopidogrel resistance in the dual and triple antiplatelet therapy groups, respectively. In all subjects, the CYP2C19*3A allele was significantly more prevalent in the clopidogrel-resistant group compared with the clopidogrel-responsive group. Multiple logistic regression analysis demonstrated that CYP2C19*3 is an independent predictor of clopidogrel resistance. In conclusion, CYP2C19*3 single-nucleotide polymorphisms is an independent risk factor of clopidogrel resistance in Korean subjects with coronary artery disease." @default.
• W2163136018 created "2016-06-24" @default.
• W2163136018 creator A5008942832 @default.
• W2163136018 creator A5017419314 @default.
• W2163136018 creator A5020654868 @default.
• W2163136018 creator A5022383639 @default.
• W2163136018 creator A5035759810 @default.
• W2163136018 creator A5051275961 @default.
• W2163136018 creator A5063360103 @default.
• W2163136018 creator A5076260925 @default.
• W2163136018 creator A5078101542 @default.
• W2163136018 creator A5080970990 @default.
• W2163136018 creator A5081680751 @default.
• W2163136018 date "2009-07-01" @default.
• W2163136018 modified "2023-10-16" @default.
• W2163136018 title "Relation of Genetic Polymorphisms in the Cytochrome P450 Gene With Clopidogrel Resistance After Drug-Eluting Stent Implantation in Koreans" @default.
• W2163136018 cites W1415139109 @default.
• W2163136018 cites W168371622 @default.
• W2163136018 cites W1972045176 @default.
• W2163136018 cites W1973791303 @default.
• W2163136018 cites W1974238774 @default.
• W2163136018 cites W2007184421 @default.
• W2163136018 cites W2007251996 @default.
• W2163136018 cites W2021341882 @default.
• W2163136018 cites W2030244779 @default.
• W2163136018 cites W2042318890 @default.
• W2163136018 cites W2052106438 @default.
• W2163136018 cites W2052922809 @default.
• W2163136018 cites W2053379248 @default.
• W2163136018 cites W2074491742 @default.
• W2163136018 cites W207590421 @default.
• W2163136018 cites W2104969665 @default.
• W2163136018 cites W2113926891 @default.
• W2163136018 cites W2114346603 @default.
• W2163136018 cites W2118791457 @default.
• W2163136018 cites W2128928935 @default.
• W2163136018 cites W2130350603 @default.
• W2163136018 cites W2135575592 @default.
• W2163136018 cites W23524587 @default.
• W2163136018 cites W31732567 @default.
• W2163136018 cites W4239335020 @default.
• W2163136018 doi "https://doi.org/10.1016/j.amjcard.2009.02.045" @default.
• W2163136018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19576320" @default.
• W2163136018 hasPublicationYear "2009" @default.
• W2163136018 type Work @default.
• W2163136018 sameAs 2163136018 @default.
• W2163136018 citedByCount "86" @default.
• W2163136018 countsByYear W21631360182012 @default.
• W2163136018 countsByYear W21631360182013 @default.
• W2163136018 countsByYear W21631360182014 @default.
• W2163136018 countsByYear W21631360182015 @default.
• W2163136018 countsByYear W21631360182016 @default.
• W2163136018 countsByYear W21631360182017 @default.
• W2163136018 countsByYear W21631360182018 @default.
• W2163136018 countsByYear W21631360182019 @default.
• W2163136018 countsByYear W21631360182020 @default.
• W2163136018 countsByYear W21631360182021 @default.
• W2163136018 crossrefType "journal-article" @default.
• W2163136018 hasAuthorship W2163136018A5008942832 @default.
• W2163136018 hasAuthorship W2163136018A5017419314 @default.
• W2163136018 hasAuthorship W2163136018A5020654868 @default.
• W2163136018 hasAuthorship W2163136018A5022383639 @default.
• W2163136018 hasAuthorship W2163136018A5035759810 @default.
• W2163136018 hasAuthorship W2163136018A5051275961 @default.
• W2163136018 hasAuthorship W2163136018A5063360103 @default.
• W2163136018 hasAuthorship W2163136018A5076260925 @default.
• W2163136018 hasAuthorship W2163136018A5078101542 @default.
• W2163136018 hasAuthorship W2163136018A5080970990 @default.
• W2163136018 hasAuthorship W2163136018A5081680751 @default.
• W2163136018 hasConcept C108215921 @default.
• W2163136018 hasConcept C126322002 @default.
• W2163136018 hasConcept C140840227 @default.
• W2163136018 hasConcept C164705383 @default.
• W2163136018 hasConcept C2777265216 @default.
• W2163136018 hasConcept C2777628954 @default.
• W2163136018 hasConcept C2777849778 @default.
• W2163136018 hasConcept C2779820409 @default.
• W2163136018 hasConcept C2780400711 @default.
• W2163136018 hasConcept C49059817 @default.
• W2163136018 hasConcept C500558357 @default.
• W2163136018 hasConcept C526171541 @default.
• W2163136018 hasConcept C62231903 @default.
• W2163136018 hasConcept C71924100 @default.
• W2163136018 hasConcept C98274493 @default.
• W2163136018 hasConceptScore W2163136018C108215921 @default.
• W2163136018 hasConceptScore W2163136018C126322002 @default.
• W2163136018 hasConceptScore W2163136018C140840227 @default.
• W2163136018 hasConceptScore W2163136018C164705383 @default.
• W2163136018 hasConceptScore W2163136018C2777265216 @default.
• W2163136018 hasConceptScore W2163136018C2777628954 @default.
• W2163136018 hasConceptScore W2163136018C2777849778 @default.
• W2163136018 hasConceptScore W2163136018C2779820409 @default.
• W2163136018 hasConceptScore W2163136018C2780400711 @default.
• W2163136018 hasConceptScore W2163136018C49059817 @default.
• W2163136018 hasConceptScore W2163136018C500558357 @default.
• W2163136018 hasConceptScore W2163136018C526171541 @default.
• W2163136018 hasConceptScore W2163136018C62231903 @default.
• W2163136018 hasConceptScore W2163136018C71924100 @default.

• next